June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

August 30, 2016August 30, 2016

New Research Shows How Melanoma Cells Reach Blood Vessels, Reveals Chemicals for Prevention

News

To reach circulation and invade other organs, melanoma cells must travel from the epidermis (outer layer of skin) where there is marked absence of blood vessels, to the dermis (deeper level ... Read more

August 25, 2016August 25, 2016

Melanomas Associated with Moles Have Better Prognosis Than Those Without Moles, Study Finds

News

Nevus-associated melanomas, or melanomas that are associated with a mole, are less likely to have an adverse histopathology than de novo melanomas, or melanomas that arise from clinically normal skin ... Read more

August 23, 2016August 23, 2016

US Preventive Services Task Force Updates Skin Cancer Screening Recommendation

News

A US Preventive Services Task Force has concluded after careful review that current evidence is insufficient to adequately determine the benefit versus harm of having clinicians conduct routine visual skin cancer screenings. The recommendation does ... Read more

August 18, 2016August 18, 2016

Opdivo Seen to Improve Life Quality in People with Advanced Melanoma

News

Nivolumab not only improves survival but also maintains or even improves health related quality of life in patients with advanced melanoma, according to a study funded by Bristol-Myers Squibb, its ... Read more

August 16, 2016August 16, 2016

Analyzing Melanoma Tumor Biopsies During Treatment Could Help Predict Patients’ Response to Therapy, Study Reports

News

Although analyzing biopsies from melanoma patients before the start of a treatment cannot reliably predict which patients will respond to treatment and which ones will not, measuring immune response in ... Read more

August 11, 2016August 11, 2016

Melanoma: Mechanism Behind BRAF-Mutant Resistance to Therapies Identified

News

Massachusetts General Hospital (MGH) researchers have identified a previously unknown mechanism that allows BRAF-mutant melanoma cells to resist targeted therapies. The study “Loss of cohesin complex components STAG2 or STAG3 confers resistance ... Read more

August 9, 2016August 9, 2016

Noncoding RNA Could Be Target for Melanoma Therapy Development

News

Inhibition of a long noncoding RNA called RMEL3 may help treat melanoma patients, including those with a BRAF mutation, according to a recent study developed by researchers at the University ... Read more

August 4, 2016August 4, 2016

Keytruda Shows Early Promise in Melanoma Brain Metastases, Study Suggests

News

Pembrolizumab, trade name Kertruda, an antibody used in cancer immunotherapy, may have therapeutic effects in brain metastases in patients with melanoma and non–small cell lung cancer (NSCLC), as suggested by ... Read more

August 2, 2016August 2, 2016

Melanoma Screenings for Atypical Moles Should Include Perianal Area

News

Patients undergoing melanoma screening and surveillance should be examined in the perianal area for melanocytic nevi, or moles, that are associated with atypical nevi elsewhere on the body, according to researchers at ... Read more

July 28, 2016July 28, 2016

Metastatic Melanomas Respond to Immunotherapy Combo in Early Clinical Study

News

The immune-therapy drug ipilimumab together with talimogene laherparepvec, or T-VEC, produced positive results in a Phase 1b clinical trial in patients with metastatic melanomas, who did not respond to other ... Read more

July 26, 2016July 26, 2016

New Compound Against Sun’s UVA Rays Might Improve Sunscreens

News

Developed by United Kingdom researchers, a new compound dubbed “mitoiron claw” can protect cells from UVA radiation in sunlight and might enhance the effects of sunscreen and skin care products that now ... Read more

July 21, 2016July 21, 2016

Immunotherapy Approach to Treat Melanoma Looks Promising, Studies Reveal

News

Blocking immune checkpoints as well as modifying T-cells could treat melanoma according to two new studies conducted by researchers at the Clinical Research Division of the Fred Hutch Cancer Research ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group